Actinium Pharmaceuticals Inc (ATNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Operating Expenses | 6,435 | 5,613 | 4,662 | 5,683 | 4,635 |
| Operating Income | -6,435 | -5,613 | -4,662 | -5,683 | -4,635 |
| Other Income | 55 | 73 | 37 | 13 | 31 |
| Pre-tax Income | -6,380 | -5,540 | -4,625 | -5,670 | -4,604 |
| Net Income Continuous | -6,380 | -5,540 | -4,625 | -5,670 | -4,604 |
| Net Income | $-6,380 | $-5,540 | $-4,625 | $-5,670 | $-4,604 |
| EPS Basic Total Ops | -0.08 | -0.36 | -0.41 | -0.98 | -0.69 |
| EPS Basic Continuous Ops | -0.09 | -0.36 | -0.41 | -0.98 | -0.74 |
| EPS Diluted Total Ops | -0.08 | -0.36 | -0.41 | -0.98 | -0.69 |
| EPS Diluted Continuous Ops | -0.09 | -0.36 | -0.41 | -0.98 | -0.74 |
| EBITDA(a) | $-6,315 | $-5,502 | $-4,554 | $-5,575 | $-4,531 |